The Royal Australian & New Zealand College of Psychiatrists (RANZCP) considers TMS to be a valid treatment option for patients with Major Depression who have not responded to two or more antidepressant medications. TMS is a short-term therapy program, a well-researched and evidence-based intervention, proven to have sustainable effects in patients with major depression, as well as OCD. When combined with Psychotherapy, studies show there is a 66% chance of response with 56% of those who respond maintaining positive effects at 6 months follow up (see Donse et al. 2017)
In this workshop participants receive hands-on training workshop, covering the use and theoretical background of Transcranial Magnetic Stimulation to treat Major Depression in clinical practice. It also presents emerging evidence as a therapy and protocols to treat OCD, as well as optimized benefits when combined with Psychotherapy and Sleep Hygiene Maintenance. Participants will receive an overview of TMS intake and safe delivery protocols. The prediction of treatment outcomes and QEEG markers of response and no-response to TMS will also be presented. The presenters will also introduce the new technique of Neuro-Cardiac Guided TMS (NCG-TMS), a state-of-the-art technique to accurately locate the DLPFC in stimulation.
This course will also present comparable neuromodulation techniques such as tDCS, tACS, tRNS (We also run a 1-day tDCS workshop separate to this course). The workshop is also suited to professionals with limited experience in neuromodulation and is supervised by industry experienced scientist and practitioner, Dr Trevor Brown and Dr Mark Ryan (see profiles below).